Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors

被引:35
作者
Cavalli, A
Greco, G
Novellino, E
Recanatini, M
机构
[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[2] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, I-80131 Naples, Italy
关键词
D O I
10.1016/S0968-0896(00)00203-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An approach to compare quantitatively a ligand-based (CoMFA) model and an enzyme active site model was investigated. The active site of the cytochrome P450 human aromatase was constructed by homology modeling techniques and two structurally different non-steroidal aromatase inhibitors were docked into it. A CoMFA model was then developed on a related series of non-steroidal inhibitors by correlating their inhibitory activity (expressed as -log IC50 values) versus only 11 steric descriptors (i.e. C-sp3-ligand steric interaction energies). The resulting 3D-QSAR coefficients (II) and the steric field values of the aromatase active site calculated at the same points of the CoMFA lattice (i.e. eleven C-sp3-protein steric interaction energies) were pair-wise compared. Specifically, when a positive coefficient was associated with a negative or low (< 5 kcal/mol) value of the protein steric field or, alternatively, a negative coefficient was associated with a large positive value of the protein steric field we recorded as many matches. When a 3D-QSAR coefficient did not correspond to the protein steric potential in the sense described above we considered that point as a mis-matching point. In our view, in spite of several limitations, such a comparison represents a valuable criterion to evaluate quantitatively how convergent are the results from a 3D-QSAR CoMFA model and a homology-built protein 3D structure. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2771 / 2780
页数:10
相关论文
共 44 条
[1]   CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTER - COMPUTER-BASED SEARCH, RETRIEVAL, ANALYSIS AND DISPLAY OF INFORMATION [J].
ALLEN, FH ;
BELLARD, S ;
BRICE, MD ;
CARTWRIGHT, BA ;
DOUBLEDAY, A ;
HIGGS, H ;
HUMMELINK, T ;
HUMMELINKPETERS, BG ;
KENNARD, O ;
MOTHERWELL, WDS ;
RODGERS, JR ;
WATSON, DG .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (OCT) :2331-2339
[2]  
BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3578
[3]  
Banting L, 1989, Prog Med Chem, V26, P253, DOI 10.1016/S0079-6468(08)70242-X
[4]  
Banting L, 1996, Prog Med Chem, V33, P147, DOI 10.1016/S0079-6468(08)70305-9
[5]   GENERATING OPTIMAL LINEAR PLS ESTIMATIONS (GOLPE) - AN ADVANCED CHEMOMETRIC TOOL FOR HANDLING 3D-QSAR PROBLEMS [J].
BARONI, M ;
COSTANTINO, G ;
CRUCIANI, G ;
RIGANELLI, D ;
VALIGI, R ;
CLEMENTI, S .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1993, 12 (01) :9-20
[6]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[7]  
*BIOS MSI, 1995, INSIGHT 2 VER 95 0 D
[8]  
Burke DF, 1997, ANTI-CANCER DRUG DES, V12, P113
[9]   Construction and evaluation of a three-dimensional structure of cytochrome P450choP enzyme (CYP105C1) [J].
Chang, YT ;
Loew, GH .
PROTEIN ENGINEERING, 1996, 9 (09) :755-766
[10]   MECHANISM AND INHIBITION OF CYTOCHROME-P-450 AROMATASE [J].
COLE, PA ;
ROBINSON, CH .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (11) :2933-2942